A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
Measles, mumps, and rubella (MMR) are highly infectious viral diseases affecting young children and have high secondary attack rates. Present MMR vaccines show consistent seroconversion rates for anti-measles and anti-rubella antibodies with variable responses for anti-mumps antibodies. Most common...
Saved in:
Main Authors: | Nitin Shah (Author), Apurba Ghosh (Author), Kishore Kumar (Author), Trayambak Dutta (Author), Manish Mahajan (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hubungan vaksin Measles, Mumps, Rubella (MMR) dengan Kejadian Autisme
by: Elsye Souvriyanti, et al.
Published: (2016) -
Improving health literacy with mumps, measles and rubella (MMR) vaccination: comparison of the readability of MMR patient-facing literature and MMR scientific abstracts
by: Tina Downey, et al.
Published: (2022) -
Clinical safety issues of measles, mumps and rubella vaccines
by: M.A. Afzal, et al.
Published: (2000) -
Mumps, Measles and Rubella Vaccination and Encephalitis
by: J Gordon Millichap
Published: (1989) -
A study to evaluate the role of intradermal and intralesional measles, mumps, rubella (MMR) vaccine in treatment of common warts
by: Pragya Gupta, et al.
Published: (2020)